Literature DB >> 21846616

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.

Laurence Katznelson1, John L D Atkinson, David M Cook, Shereen Z Ezzat, Amir H Hamrahian, Karen K Miller.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21846616     DOI： 10.4158/ep.17.s4.1

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  87 in total

Review 1.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

Review 2.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

Review 3.  Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.

Authors:  Avital Perry; Christopher Salvatore Graffeo; Christopher Marcellino; Bruce E Pollock; Nicholas M Wetjen; Fredric B Meyer
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-24

4.  Biochemical and quality of life responses to octreotide-LAR in acromegaly.

Authors:  Ruth Mangupli; Paul Camperos; Susan M Webb
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

5.  Quantifying subtle changes in cardiovascular mechanics in acromegaly: a Doppler myocardial imaging study.

Authors:  R Jurcut; S Găloiu; A Florian; A Vlădaia; O R Ioniţă; M S Amzulescu; I Baciu; B A Popescu; M Coculescu; C Ginghina
Journal:  J Endocrinol Invest       Date:  2014-08-15       Impact factor: 4.256

6.  Expression of the pituitary stem/progenitor marker GFRα2 in human pituitary adenomas and normal pituitary.

Authors:  Nestoras Mathioudakis; Ram Sundaresh; Alexandra Larsen; William Ruff; Jennifer Schiller; Hugo Guerrero-Cázares; Peter Burger; Roberto Salvatori; Alfredo Quiñones-Hinojosa
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

7.  Predictive value of T2 relative signal intensity for response to somatostatin analogs in newly diagnosed acromegaly.

Authors:  Ming Shen; Qilin Zhang; Wenjuan Liu; Meng Wang; Jingjing Zhu; Zengyi Ma; Wenqiang He; Shiqi Li; Xuefei Shou; Yiming Li; Zhaoyun Zhang; Hongying Ye; Min He; Bin Lu; Zhenwei Yao; Yun Lu; Nidan Qiao; Zhao Ye; Yichao Zhang; Yeping Yang; Yao Zhao; Yongfei Wang
Journal:  Neuroradiology       Date:  2016-08-11       Impact factor: 2.804

8.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

Review 9.  The role of combination medical therapy in the treatment of acromegaly.

Authors:  Dawn Shao Ting Lim; Maria Fleseriu
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

10.  Safety and efficacy of repeat radiosurgery for acromegaly: an International Multi-Institutional Study.

Authors:  Clayton E Alonso; Adomas Bunevicius; Daniel M Trifiletti; James Larner; Cheng-Chia Lee; Fu-Yuan Pai; Roman Liscak; Mikulas Kosak; Hideyuki Kano; Nathaniel D Sisterson; David Mathieu; L Dade Lunsford; Jason P Sheehan
Journal:  J Neurooncol       Date:  2019-09-20       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.